Maarten Altelaar

37PUBLICATIONS
210CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsProtein traffickingGenome structure and regulationApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jul 28, 2026
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator.

|May 28, 2026
(Phospho)proteomic Profiling Reveals Mutation-Specific Adaptive Signaling to PI3Kα Inhibition in PIK3CA Mutant Breast Epithelial Cells.

|Feb 18, 2026
Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms.

Charlie George Barker, Sumana Sharma, Ana Mafalda Santos

|Nov 28, 2025
Inhibition of TBK1/IKKε mediated RIPK1 phosphorylation sensitizes tumors to immune cell killing.

Anastasia Piskopou, David W Vredevoogd, Xiangjun Kong

|Jul 04, 2025
Cytidine diphosphate diacylglycerol synthase 2 is a synthetic lethal target in mesenchymal-like cancers.

Tim Arnoldus, Alex van Vliet, Onno B Bleijerveld

|Jun 24, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko

Pageof 7

Frequent Collaborators

6 joint publications

Albert J R Heck

6 joint publications

Liesbeth Hoekman

4 joint publications

Wilbert Zwart

4 joint publications

Onno Bleijerveld